These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 18793280)
41. Literature review on the genotoxicity, reproductive toxicity, and carcinogenicity of ethyl methanesulfonate. Gocke E; Bürgin H; Müller L; Pfister T Toxicol Lett; 2009 Nov; 190(3):254-65. PubMed ID: 19857796 [TBL] [Abstract][Full Text] [Related]
42. Does scientific evidence support a change from the LNT model for low-dose radiation risk extrapolation? Averbeck D Health Phys; 2009 Nov; 97(5):493-504. PubMed ID: 19820459 [TBL] [Abstract][Full Text] [Related]
43. U-shaped dose-response curves: their occurrence and implications for risk assessment. Davis JM; Svendsgaard DJ J Toxicol Environ Health; 1990 Jun; 30(2):71-83. PubMed ID: 2192070 [TBL] [Abstract][Full Text] [Related]
44. The hormesis concept and risk assessment: are there unique ethical and policy considerations? Hoffmann G; Stempsey W Hum Exp Toxicol; 2008 Aug; 27(8):613-20. PubMed ID: 19029257 [TBL] [Abstract][Full Text] [Related]
46. Mechanism of apicidin-induced cell cycle arrest and apoptosis in Ishikawa human endometrial cancer cells. Ahn MY; Lee J; Na YJ; Choi WS; Lee BM; Kang KW; Kim HS Chem Biol Interact; 2009 May; 179(2-3):169-77. PubMed ID: 19070610 [TBL] [Abstract][Full Text] [Related]
47. Stress biology and hormesis: the Yerkes-Dodson law in psychology--a special case of the hormesis dose response. Calabrese EJ Crit Rev Toxicol; 2008; 38(5):453-62. PubMed ID: 18568865 [TBL] [Abstract][Full Text] [Related]
48. Hormesis predicts low-dose responses better than threshold models. Calabrese EJ; Stanek EJ; Nascarella MA; Hoffmann GR Int J Toxicol; 2008; 27(5):369-78. PubMed ID: 19037807 [TBL] [Abstract][Full Text] [Related]
51. Sensitivity analysis of biologically motivated model for formaldehyde-induced respiratory cancer in humans. Crump KS; Chen C; Fox JF; Van Landingham C; Subramaniam R Ann Occup Hyg; 2008 Aug; 52(6):481-95. PubMed ID: 18628253 [TBL] [Abstract][Full Text] [Related]
52. Dehydroepiandrosterone inhibits the proliferation and induces the death of HPV-positive and HPV-negative cervical cancer cells through an androgen- and estrogen-receptor independent mechanism. Girón RA; Montaño LF; Escobar ML; López-Marure R FEBS J; 2009 Oct; 276(19):5598-609. PubMed ID: 19702826 [TBL] [Abstract][Full Text] [Related]
53. Assessing dose-response relationships by cumulative exposures in epidemiological studies. Axelson O; Forastiere F; Frederickson M Am J Ind Med; 2007 Mar; 50(3):217-20. PubMed ID: 17315178 [TBL] [Abstract][Full Text] [Related]
54. Energy balance, physical activity, and cancer risk. Fair AM; Montgomery K Methods Mol Biol; 2009; 472():57-88. PubMed ID: 19107429 [TBL] [Abstract][Full Text] [Related]
56. [Quantitative methods of cancer risk assessment in exposure to chemicals]. Szymczak W Med Pr; 2009; 60(3):215-21. PubMed ID: 19746890 [TBL] [Abstract][Full Text] [Related]
58. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]